Literature DB >> 3345071

Prospective nerve conduction studies in cisplatin therapy.

J E Riggs1, M Ashraf, R D Snyder, L Gutmann.   

Abstract

We studied nerve conduction prospectively in 38 women receiving cisplatin for gynecological malignancies. Decreased sensory nerve action potential amplitudes and prolonged sensory latencies were the only significant changes identified. This prospective electrophysiological study validates the clinical observation of frequent sensory symptoms and occasional sensory neuropathies associated with cisplatin therapy.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3345071     DOI： 10.1002/ana.410230116

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


  6 in total

1.  In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.

Authors:  C C Verstappen; A A Geldof; T J Postma; J J Heimans
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Cisplatin induced neuropathy: central, peripheral and autonomic nerve involvement.

Authors:  W Boogerd; W W ten Bokkel Huinink; O Dalesio; W J Hoppenbrouwers; J J van der Sande
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

Review 3.  Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.

Authors:  Carla C P Verstappen; Jan J Heimans; Klaas Hoekman; Tjeerd J Postma
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Cisplatin neuropathy: clinical course and neurophysiological findings.

Authors:  M LoMonaco; M Milone; A P Batocchi; L Padua; D Restuccia; P Tonali
Journal:  J Neurol       Date:  1992-04       Impact factor: 4.849

5.  Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats.

Authors:  G Cavaletti; G Tredici; P Marmiroli; M G Petruccioli; I Barajon; D Fabbrica
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis.

Authors:  M von Schlippe; C J Fowler; S J Harland
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.